This approach was extensively tested in the KRASG12V-driven mouse model of NSCLC and the outcome of many experiments all point to a pivotal importance of the MAPK [71, 72] and PI3K pathway [73, 74] in the propagation of mutant KRAS’s oncogenic signals. This evidence concerns the gene KRAS and non-small cell lung carcinoma.